Small molecule ectonucleotide pyrophosphatase/phosphodiesterase 1 inhibitors in cancer immunotherapy for harnessing innate immunity

被引：5
|
作者：
Choi, Junwon [1 ]
机构：
[1] Ajou Univ, Dept Mol Sci & Technol, Suwon, Gyeonggi, South Korea
来源：
BULLETIN OF THE KOREAN CHEMICAL SOCIETY | 2023年 / 44卷 / 02期
基金：
新加坡国家研究基金会;
关键词：
cancer immunotherapy; cGAMP; ENPP1; inhibitor; innate immunity; STING; CYCLIC GMP-AMP; NUCLEOTIDE PYROPHOSPHATASE; EXTRACELLULAR CGAMP; POTENT INHIBITORS; BYSTANDER CELLS; HUMAN NPP1; DERIVATIVES; HYDROLYSIS; 2ND-MESSENGER; ENPP1;
D O I：
10.1002/bkcs.12646
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) was recently identified as a major hydrolase of an endogenous stimulator of interferon genes (STING) agonist, 2 ',3 '-cyclic guanosine monophosphate-adenosine monophosphate (cGAMP). ENPP1 is a promising therapeutic target in cancer immunotherapy, in which the inhibition of ENPP1 enhances anticancer immunity via STING-mediated innate immune activation. This review highlights the role of ENPP1 in innate immunity and the recent discovery of small molecule ENPP1 inhibitors as immunomodulators in cancer immunotherapy.
引用
收藏
页码：88 / 99
页数：12
相关论文
共 50 条
  • [41] Discovery and characterization of small molecule Rac1 inhibitors
    Arnst, Jamie L.
    Hein, Ashley L.
    Taylor, Margaret A.
    Palermo, Nick Y.
    Contreras, Jacob I.
    Sonawane, Yogesh A.
    Wahl, Andrew O.
    Ouellette, Michel M.
    Natarajan, Amarnath
    Yan, Ying
    ONCOTARGET, 2017, 8 (21) : 34586 - 34600
  • [42] Combinatorial cancer immunotherapy strategies with proapoptotic small-molecule IAP antagonists
    Beug, Shawn T.
    Conrad, David P.
    Alain, Tommy
    Korneluk, Robert G.
    Lacasse, Eric C.
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2015, 59 (1-3) : 141 - 147
  • [43] Novel Small Molecule Inhibitors of Cancer Stem Cell Signaling Pathways
    Abetov, Danysh
    Mustapova, Zhanar
    Saliev, Timur
    Bulanin, Denis
    Batyrbekov, Kanat
    Gilman, Charles P.
    STEM CELL REVIEWS AND REPORTS, 2015, 11 (06) : 909 - 918
  • [44] Peptide-based and small synthetic molecule inhibitors on PD-1/PD-L1 pathway: A new choice for immunotherapy?
    Chen, Tingkai
    Li, Qi
    Liu, Zongliang
    Chen, Yao
    Feng, Feng
    Sun, Haopeng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 161 : 378 - 398
  • [45] Novel Small Molecule Inhibitors of Cancer Stem Cell Signaling Pathways
    Danysh Abetov
    Zhanar Mustapova
    Timur Saliev
    Denis Bulanin
    Kanat Batyrbekov
    Charles P. Gilman
    Stem Cell Reviews and Reports, 2015, 11 : 909 - 918
  • [46] Advances in CD73 inhibitors for immunotherapy: Antibodies, synthetic small molecule compounds, and natural compounds
    Zhang, Mingxue
    Dai, Xiaoqin
    Xiang, Yu
    Xie, Linshen
    Sun, Minghan
    Shi, Jianyou
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 258
  • [47] The development of small-molecule inhibitors targeting HPK1
    Zhou, Lixin
    Wang, Tianyu
    Zhang, Kuojun
    Zhang, Xiangyu
    Jiang, Sheng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 244
  • [48] Rational design of small molecule inhibitors targeting ASK1
    Volynets, G. P.
    Starosyla, S. A.
    Bdzhola, V. G.
    Yarmoluk, S. M.
    FEBS JOURNAL, 2014, 281 : 417 - 418
  • [49] Identification and structural characterization of small molecule inhibitors of PINK1
    Rasool S.
    Shomali T.
    Truong L.
    Croteau N.
    Veyron S.
    Bustillos B.A.
    Springer W.
    Fiesel F.C.
    Trempe J.-F.
    Scientific Reports, 14 (1)
  • [50] Development of small-molecule immune checkpoint inhibitors of PD-1/PD-L1 as a new therapeutic strategy for tumour immunotherapy
    Li, Kui
    Tian, Hongqi
    JOURNAL OF DRUG TARGETING, 2019, 27 (03) : 244 - 256
12345